Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 89.45B | 77.33B | 71.58B | 69.20B | 75.76B |
Gross Profit | 21.72B | 17.85B | 16.82B | 16.32B | 16.83B |
EBITDA | 3.85B | 3.44B | 3.08B | 3.00B | 3.31B |
Net Income | 1.50B | 1.45B | 1.19B | 1.33B | 1.40B |
Balance Sheet | |||||
Total Assets | 39.83B | 38.09B | 33.50B | 32.17B | 32.62B |
Cash, Cash Equivalents and Short-Term Investments | 4.46B | 3.96B | 2.36B | 1.24B | 2.87B |
Total Debt | 6.27B | 6.79B | 5.33B | 5.32B | 6.22B |
Total Liabilities | 19.03B | 18.72B | 15.72B | 15.45B | 17.15B |
Stockholders Equity | 20.80B | 19.37B | 17.78B | 16.72B | 15.47B |
Cash Flow | |||||
Free Cash Flow | 1.76B | 2.73B | 1.68B | 99.34M | 2.19B |
Operating Cash Flow | 3.10B | 3.78B | 2.54B | 1.73B | 3.37B |
Investing Cash Flow | -1.37B | -2.89B | -864.63M | -1.95B | -1.18B |
Financing Cash Flow | -1.23B | 700.91M | -556.83M | -1.41B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥12.71B | 11.69 | 1.07% | 6.01% | -21.51% | ||
75 Outperform | ¥12.66B | 7.93 | 2.19% | 14.35% | 11.49% | ||
75 Outperform | ¥8.76B | 12.15 | 4.49% | 1.96% | 4.38% | ||
71 Outperform | ¥11.15B | 8.13 | 1.46% | 0.43% | 2.70% | ||
62 Neutral | HK$21.76B | 9.92 | 5.51% | 4.81% | 1.24% | -22.96% | |
53 Neutral | ¥12.71B | ― | 2.31% | 1.28% | -449.59% | ||
38 Underperform | ¥8.16B | ― | ― | -10.64% | -13.47% |